Nir Sassi's Net Worth
$0
Who is Nir Sassi?
Nir Sassi does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Intec Pharma Ltd., and Indaptus Therapeutics, Inc..
SEC CIK
Nir Sassi's CIK is 0001760673
Past Insider Trading and Trends
2019 was Nir Sassi's most active year for acquiring shares with 2 total transactions. Nir Sassi's most active month to acquire stocks was the month of December. 2019 saw Nir Sassi paying a total of $0.00 for 290,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Intec Pharma Ltd. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Indaptus Therapeutics, Inc. (INDP) Snapshot price: $1.49
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||